Bay Shore Trust bought TELO
February 13, 2024 · Form 4 insider transaction
Bay Shore Trust bought 49,000 shares of Telomir Pharmaceuticals, Inc. at $7.00 per share, a transaction worth $343.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
49,000
Price
$7.00
Total value
$343.0K
InsiderBay Shore Trust
Role10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 13, 2024
Filing dateFebruary 15, 2024
Shares owned after5,455,431
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.